Noninvasive Ventilation for Acute Exacerbations of COPD
EBM, Landmark Research
Oral Apixaban for the Treatment of Acute Venous Thromboembolism (AMPLIFY)
EBM, Landmark Research
Medical Jeopardy: Anticoagulation for Venous Thromboembolism
Noon Conference
Test and review your knowledge about VTE and management with anticoagulation.
Strange Behavior in a Patient with HIV
Morning Report
What’s your differential diagnosis to explain the “strange behavior” of a patient with newly diagnosed HIV/AIDS?
Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries
EBM, Journal Club
Do you ever give NSAID’s to patients with cardiomyopathy? Usually not, and here is evidence supporting why we don’t. But are there some NSAID’s that have less unfavorable outcomes?
Rifaximin Plus Lactulose Versus Lactulose Alone in Treatment of Overt Hepatic Encephalopathy
EBM, Landmark Research
Lactulose is widely used for treatment of hepatic encephalopathy because it is effective, cheap, and widely available. So is there any benefit to using Rifaximin in patients with hepatic encephalopathy? Here are some questions to answer when reviewing this article…
LMWH versus Warfarin for the Prevention of Recurrent VTE in Patients with Cancer (CLOT Trial)
EBM, Landmark Research
Low-molecular-weight heparin (LMWH) rather than warfarin is routinely recommended for patients with venous thromboembolism (VTE) and active cancer. Much of that is based on this article. Think about these as you review the article: Clinical Question: In patients with cancer…
Resident Reflection Rounds
Noon Conference
Today, we took some time to reflect on our patient and personal experiences. What did you take away?
Reduced Cardiovascular and Renal Events with Canaglifozin (CANVAS + CANVAS-R)
EBM, Journal Club
Thank you, Alex, for a review of outcome data for one of the newest diabetes medications: canaglifozin (Invokana®). Canaglifozin is a SGLT2 inhibitor, which decreases reabsorption of glucose in the renal tubules. Clinical Question: Among patients with DM2 at high risk…
Time-to-Furosemide Treatment and Mortality in Patients Hospitalized with Acute Heart Failure
EBM, Journal Club
Key Discussion Points: Early treatment of acute heart failure with loop diuretics lowers mortality despite initial mortality risk, and this treatment strategy might be even more effective in high-risk AHF patients Earlier treatment/identification of acute heart failure relied heavily on…